Immunology - Immune Responses Flashcards

(50 cards)

1
Q

Acute-phase reactants

  • General
  • Positive (upregulated)
    • Serum amyloid A
    • C-reactive protein
    • Ferritin
    • Fibrinogen
    • Hepcidin
  • Negative (downregulated)
    • Albumin
    • Transferrin
A
  • General
    • Factors whose serum concentrations change significantly in response to inflammation
    • Produced by the liver in both acute and chronic inflammatory states.
    • Induced by IL-6, IL-1, TNF-α, and IFN-γ.
  • Positive (upregulated)
    • Serum amyloid A
      • Prolonged elevation can lead to amyloidosis.
    • C-reactive protein
      • Opsonin; fixes complement and facilitates phagocytosis.
      • Measured clinically as a sign of ongoing inflammation.
    • Ferritin
      • Binds and sequesters iron to inhibit microbial iron scavenging.
    • Fibrinogen
      • Coagulation factor
      • Promotes endothelial repair
      • Correlates with ESR
    • Hepcidin
      • Prevents release of iron bound by ferritin –>Ž anemia of chronic disease.
  • Negative (downregulated)
    • Albumin
      • Reduction conserves amino acids for positive reactants.
    • Transferrin
      • Internalized by macrophages to sequester iron.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Complement (204)

  • Overview
  • Activation
  • Functions
  • Opsonins
  • Inhibitors
A
  • Overview
    • System of interacting plasma proteins that play a role in innate immunity and inflammation.
    • MAC defends against gram-negative bacteria.
  • Activation
    • Classic** pathway—Ig_G_** or IgM mediated.
      • GM makes classic cars.
    • Alternative pathway—microbe surface molecules.
    • Lectin pathway—mannose or other sugars on microbe surface.
  • Functions
    • C3b—opsonization.
      • C3b** _b_inds bacteria.**
    • C3a**, C4**a**, C5**a****anaphylaxis.
    • C5a—neutrophil chemotaxis.
    • C5b-9—cytolysis by membrane attack complex (MAC).
  • Opsonins
    • C3b and IgG are the two 1° opsonins in bacterial defense
    • C3b also helps clear immune complexes.
  • Inhibitors
    • Decay-accelerating factor (DAF, aka CD55) and C1 esterase inhibitor help prevent complement activation on self cells (e.g., RBC).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complement disorders

  • C1 esterase inhibitor deficiency
  • C3 deficiency
  • C5–C9 deficiencies
  • DAF (GPI anchored enzyme) deficiency
A
  • C1 esterase inhibitor deficiency
    • Causes hereditary angioedema.
    • ACE inhibitors are contraindicated.
  • C3 deficiency
    • Increases risk of severe, recurrent pyogenic sinus and respiratory tract infections
    • Increases susceptibility to type III hypersensitivity reactions.
  • C5–C9 deficiencies
    • Increase susceptibility to recurrent Neisseria bacteremia.
  • DAF (GPI anchored enzyme) deficiency
    • Causes complement-mediated lysis of RBCs and paroxysmal nocturnal hemoglobinuria.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Important cytokines:
L 1-6 (mnemonic)

A
  • Hot T-bone stEAK
  • IL-1: fever (hot).
  • IL-2: stimulates T cells.
  • IL-3: stimulates bone marrow.
  • IL-4: stimulates IgE production.
  • IL-5: stimulates IgA production.
  • IL-6: stimulates aKute-phase protein production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IL-1

A
  • Secreted by macrophages
  • An endogenous pyrogen, also called osteoclast-activating factor.
  • Causes fever, acute inflammation.
  • Activates endothelium to express adhesion molecules
  • Induces chemokine secretion to recruit leukocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IL-6

A
  • Secreted by macrophages
  • An endogenous pyrogen.
  • Also secreted by Th2 cells.
  • Causes fever and stimulates production of acute-phase proteins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IL-8

A
  • Secreted by macrophages
  • Major chemotactic factor for neutrophils.
  • Neutrophils are recruited by IL-8 to clear infections.
    • “Clean up on aisle 8.”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IL-12

A
  • Secreted by macrophages
  • Induces differentiation of T cells into Th1 cells.
  • Activates NK cells.
  • Also secreted by B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TNF-a

A
  • Secreted by macrophages
  • Mediates septic shock.
  • Activates endothelium.
  • Causes leukocyte recruitment, vascular leak.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IL-2

A
  • Secreted by all T cells
  • Stimulates growth of helper, cytotoxic, and regulatory T cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IL-3

A
  • Secreted by all T cells
  • Supports the growth and differentiation of bone marrow stem cells.
  • Functions like GM-CSF.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interferon-γ

A
  • From Th1 cells
  • Has antiviral and antitumor properties.
  • Activates NK cells to kill virus-infected cells
  • Increases MHC expression and antigen presentation in all cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IL-4

A
  • From Th2 cells
  • Induces differentiation into Th2 cells.
  • Promotes growth of B cells.
  • Enhances class switching to IgE and IgG.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IL-5

A
  • From Th2 cells
  • Promotes differentiation of B cells.
  • Enhances class switching to IgA.
  • Stimulates the growth and differentiation of eosinophils.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IL-10

A
  • From Th2 cells
  • Modulates inflammatory response.
  • Inhibits actions of activated T cells and Th1.
  • Also secreted by regulatory T cells.
  • TGF-β has similar actions to IL-10, because it is involved in inhibiting inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Interferon α and β

A
  • A part of innate host defense against both RNA and DNA viruses.
  • Interferons are glycoproteins synthesized by viral-infected cells that act locally on uninfected cells, “priming them” for viral defense.
    • Interferes with viruses.
  • When a virus infects “primed” cells, viral dsRNA activates:
    • RNAase L Ž–> degradation of viral/host mRNA.
    • Protein kinase –>Ž inhibition of viral/host protein synthesis.
  • Essentially results in apoptosis, thereby interrupting viral amplification.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cell surface proteins

  • All except mature RBCs have…
  • T cells
  • Helper T cells
  • Cytotoxic T cells
  • B cells
  • Macrophages
  • NK cells
A
  • All cells except mature RBCs have MHC I.
  • T cells
    • TCR (binds antigen-MHC complex)
    • CD3 (associated with TCR for signal transduction)
    • CD28 (binds B7 on APC)
  • Helper T cells
    • CD4, CD40 ligand
  • Cytotoxic T cells
    • CD8
  • B cells
    • Ig (binds antigen)
    • CD19, CD20, CD21 (receptor for EBV), CD40
    • MHC II, B7
    • You can drink Beer at the Bar when you’re 21
      • ​__B cells, Epstein-Barr virus; CD-_21_.
  • Macrophages
    • CD14, CD40
    • MHC II, B7
    • Fc and C3b receptors (enhanced phagocytosis)
  • NK cells
    • CD16 (binds Fc of IgG)
    • CD56 (unique marker for NK)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anergy

A
  • Self-reactive T cells become nonreactive without costimulatory molecule.
  • B cells also become anergic, but tolerance is less complete than in T cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Effects of bacterial toxins

  • Superantigens
  • Endotoxins/lipopolysaccharide
A
  • Superantigens (S. pyogenes and S. aureus)
    • Cross-link the β region of the T-cell receptor to the MHC class II on APCs.
    • Can activate any T cell, leading to massive release of cytokines.
  • Endotoxins/lipopolysaccharide (gram-negative bacteria)
    • Directly stimulate macrophages by binding to endotoxin receptor CD14
    • Th cells are not involved.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Antigenic variation

  • Classic examples
    • Bacteria
    • Virus
    • Parasites
  • Some mechanisms for variation
A
  • Classic examples:
    • Bacteria
      • Salmonella (2 flagellar variants)
      • Borrelia (relapsing fever)
      • Neisseria gonorrhoeae (pilus protein).
    • Virus
      • Influenza (major = shift, minor = drift).
    • Parasites
      • Trypanosomes (programmed rearrangement).
  • Some mechanisms for variation
    • DNA rearrangement
    • RNA segment reassortment (e.g., influenza major shift).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Passive vs. active immunity

  • Means of acquisition
  • Onset
  • Duration
  • Examples
  • Notes
A
  • Means of acquisition
    • P: Receiving preformed antibodies
    • A: Exposure to foreign antigens
  • Onset
    • P: Rapid
    • A: Slow
  • Duration
    • P: Short span of antibodies (half-life = 3 weeks)
    • A: Long-lasting protection (memory)
  • Examples
    • P: IgA in breast milk, maternal IgG crossing placenta, antitoxin, humanized monoclonal antibody
    • A: Natural infection, vaccines, toxoid
  • Notes
    • P: After exposure to Tetanus toxin, Botulinum toxin, HBV, or Rabies virus, patients are given preformed antibodies (passive)
      • To Be Healed Rapidly”
    • A: Combined passive and active immunizations can be given for hepatitis B or rabies exposure
22
Q

Vaccination

  • Vaccines
  • Live attenuated vaccine vs. Inactivated or killed vaccine
    • Description
    • Pros
    • Cons
    • Examples
A
  • Vaccines
    • Used to induce an active immune response (humoral and/or cellular) to specific pathogens.
  • Live attenuated vaccine vs. inactivated or killed vaccine
    • Description
      • L: Microorganism loses its pathogenicity but retains capacity for transient growth within inoculated host.
        • Mainly induces a cellular response.
      • I/K: Pathogen is inactivated by heat or chemicals
        • Maintaining epitope structure on surface antigens is important for immune response.
        • Humoral immunity induced.
    • Pros
      • L: Induces strong, often lifelong immunity.
      • I/K: Stable and safer than live vaccines.
    • Cons
      • L: May revert to virulent form.
        • Often contraindicated in pregnancy and immune deficiency.
      • I/K: Weaker immune response
        • Booster shots usually required.
    • Examples
      • L: Measles, mumps, rubella, polio (Sabin), influenza (intranasal), varicella, yellow fever.
      • I/K: Cholera, hepatitis A, polio (Salk), influenza (injection), rabies.
23
Q

Type I hypersensitivity

  • Reaction
  • Types I, II, and III
  • Test
A
  • Reaction
    • Anaphylactic and atopic—free antigen crosslinks IgE on presensitized mast cells and basophils, triggering immediate release of vasoactive amines that act at postcapillary venules (i.e., histamine).
    • Reaction develops rapidly after antigen exposure because of preformed antibody.
    • Delayed response follows due to production of arachidonic acid metabolites (e.g., leukotrienes).
    • First (type) and Fast (anaphylaxis).
  • Types I, II, and III
    • All antibody mediated.
  • Test
    • Skin test for specific IgE.
24
Q

Type II hypersensitivity

  • Reaction
  • Mechanisms
  • Test
A
  • Reaction
    • Cytotoxic (antibody mediated)
    • IgM, IgG bind to fixed antigen on “enemy” cell, leading to cellular destruction.
    • Antibody and complement lead to membrane attack complex (MAC).
    • Type II is cy-_2_-toxic.
  • 3 mechanisms:
    • ƒƒOpsonization leading to phagocytosis or complement activation
    • Complement-mediated lysis
    • Antibody-dependent cell-mediated cytotoxicity, usually due to NK cells or macrophages
  • Test
    • Direct Coombs’: detects antibodies that have adhered to patient’s RBCs (e.g., test an Rh (+) infant of an Rh (-) mother).
    • Indirect Coombs’: detects antibodies that can adhere to other RBCs (e.g., test an Rh (-) woman for Rh (+) antibodies).
25
Type III hypersensitivity * Reaction * Serum sickness * Arthus reaction * Test
* Immune complex * Antigen-antibody (IgG) complexes activate complement, which attracts neutrophils * Neutrophils release lysosomal enzymes. * **In type _III_ reaction, imagine an immune complex as _3_ things stuck together: antigen-antibody-complement.** * **Serum sickness** * An immune complex disease (type III) in which antibodies to the foreign proteins are produced (takes 5 days). * Immune complexes form and are deposited in membranes, where they fix complement (leads to tissue damage). * More common than Arthus reaction. * Most serum sickness is now caused by drugs (not serum) acting as haptens. * Fever, urticaria, arthralgias, proteinuria, lymphadenopathy 5–10 days after antigen exposure. * **Arthus reaction** * A local subacute antibody-mediated hypersensitivity (type III) reaction. * Intradermal injection of antigen induces antibodies, which form antigen-antibody complexes in the skin. * Characterized by edema, necrosis, and activation of complement. * Antigen-antibody complexes cause the Arthus reaction. * Test * Immunofluorescent staining.
26
Type IV hypersensitivity * Reaction * Test * Mnemonic
* Delayed (T-cell-mediated) type * Sensitized T lymphocytes encounter antigen and then release lymphokines * Leads to macrophage activation * No antibody involved * Cell mediated * Therefore, it is not transferable by serum. * **_4th_ and _last_—delayed.** * Test * Patch test, PPD. * **_4_ _T_’s** * **_T_** lymphocytes * **_T_**ransplant rejections * **_T_**B skin tests * **_T_**ouching (contact dermatitis).
27
Hypersensitivity types (mnemomnic)
* **_ACID_** * **_A_**naphylactic and **_A_**topic (_type I_) * **_C_**ytotoxic (antibody mediated) (_type II_) * **_I_**mmune complex (_type III_) * **_D_**elayed (cell mediated) (_type IV_)
28
Hypersensitivity disorders * For each * Examples * Presentation * Type I * Type II * Type III * Type IV
* Type I * Examples * Anaphylaxis (e.g., bee sting, some food/drug allergies) * Allergic and atopic disorders (e.g., rhinitis, hay fever, eczema, hives, asthma) * Presentation * Immediate, anaphylactic, atopic * Type II * Examples * Autoimmune hemolytic anemia * Pernicious anemia * Idiopathic thrombocytopenic purpura * Erythroblastosis fetalis * Acute hemolytic transfusion reactions * Rheumatic fever * Goodpasture syndrome * Bullous pemphigoid * Pemphigus vulgar * Presentation * Disease tends to be specific to tissue or site where antigen is found * Type III * Examples * SLE * Polyarteritis nodosa * Poststreptococcal glomerulonephritis * Serum sickness * Arthus reaction (e.g., swelling and inflammation following tetanus vaccine) * Presentation * Can be associated with vasculitis and systemic manifestations * Type IV * Examples * Multiple sclerosis * Guillain-Barré syndrome * Graft-versus-host disease * PPD (test for M. tuberculosis) * Contact dermatitis (e.g., poison ivy, nickel allergy) * Presentation * Response is delayed and does not involve antibodies (vs. types I, II, and III)
29
Blood transfusion reactions * For each * Pathogenesis * Clinical presentation * Allergic reaction * Anaphylactic reaction * Febrile nonhemolytic transfusion reaction * Acute hemolytic transfusion reaction
* Allergic reaction * _P_: Type I hypersensitivity reaction against plasma proteins in transfused blood. * _C_: Urticaria, pruritus, wheezing, fever. * Treat with antihistamines. * Anaphylactic reaction * _P_: Severe allergic reaction. * IgA-deficient individuals must receive blood products that lack IgA. * _C_: Dyspnea, bronchospasm, hypotension, respiratory arrest, shock. * Febrile nonhemolytic transfusion reaction * _P_: Type II hypersensitivity reaction. * Host antibodies against donor HLA antigens and leukocytes. * _C_: Fever, headaches, chills, flushing. * Acute hemolytic transfusion reaction * _P_: Type II hypersensitivity reaction. * Intravascular hemolysis (ABO blood group incompatibility) or extravascular hemolysis (host antibody reaction against foreign antigen on donor RBCs). * _C_: Fever, hypotension, tachypnea, tachycardia, flank pain, hemoglobinemia (intravascular), jaundice (extravascular hemolysis).
30
Associated disorders of these autoantibodies * Anti-ACh receptor * Anti-basement membrane * Anti-cardiolipin, lupus anticoagulant * Anticentromere * Anti-desmoglein * Anti-dsDNA, anti-Smith * Anti-glutamate decarboxylase * Anti-hemidesmosome * Antihistone * Anti-Jo-1, anti-SRP, anti-Mi-2 * Antimicrosomal, antithyroglobulin * Antimitochondrial * Antinuclear antibodies * Anti-Scl-70 (anti-DNA topoisomerase I) * Anti-smooth muscle * Anti-SSA, anti-SSB (anti-Ro, anti-La) * Anti-TSH receptor * Anti-U1 RNP (ribonucleoprotein) * c-ANCA (PR3-ANCA) * IgA antiendomysial, IgA anti-tissue transglutaminase * p-ANCA (MPO-ANCA) * Rheumatoid factor (antibody, most commonly IgM, specific to IgG Fc region), anti-CCP
* Anti-ACh receptor * Myasthenia gravis * Anti-basement membrane * Goodpasture syndrome * Anti-cardiolipin, lupus anticoagulant * SLE, antiphospholipid syndrome * Anticentromere * Limited scleroderma (CREST syndrome) * Anti-desmoglein * Pemphigus vulgaris * Anti-dsDNA, anti-Smith * SLE * Anti-glutamate decarboxylase * Type 1 diabetes mellitus * Anti-hemidesmosome * Bullous pemphigoid * Antihistone * Drug-induced lupus * Anti-Jo-1, anti-SRP, anti-Mi-2 * Polymyositis, dermatomyositis * Antimicrosomal, antithyroglobulin * Hashimoto thyroiditis * Antimitochondrial * 1° biliary cirrhosis * Antinuclear antibodies * SLE, nonspecific * Anti-Scl-70 (anti-DNA topoisomerase I) * Scleroderma (diffuse) * Anti-smooth muscle * Autoimmune hepatitis * Anti-SSA, anti-SSB (anti-Ro, anti-La) * Sjögren syndrome * Anti-TSH receptor * Graves disease * Anti-U1 RNP (ribonucleoprotein) * Mixed connective tissue disease * c-ANCA (PR3-ANCA) * Granulomatosis with polyangiitis (Wegener) * IgA antiendomysial, IgA anti-tissue transglutaminase * Celiac disease * p-ANCA (MPO-ANCA) * Microscopic polyangiitis, Churg-Strauss syndrome * Rheumatoid factor (antibody, most commonly IgM, specific to IgG Fc region), anti-CCP * Rheumatoid arthritis
31
Infections in immunodeficiency * B-cell vs. T-cell deficiencies * Bacteria * No T cells * No B cells * No granulocyte * No complement * Virus * No T cells * No B cells * Fungi/parasites * No T cells * No B cells * No granulocyte
* B-cell vs. T-cell deficiencies * B-cell deficiencies tend to produce recurrent bacterial infections * T-cell deficiencies produce more fungal and viral infections. * Bacteria * _No T cells_: Sepsis * _No B cells_: Encapsulated (**_SHiNE_ _SK**_i_**S_**) * **_S_**treptococcus pneumoniae * **_H_**aemophilus **_i_**nfluenzae type B * **_N_**eisseria meningitidis * **_E_**scherichia coli * **_S_**almonella * **_K_**lebsiella pneumoniae * Group B **_S_**trep * _No granulocyte_: Staphylococcus, Burkholderia cepacia, Serratia, Nocardia * _No complement_: Neisseria (no membrane attack complex) * Virus * _No T cells_: CMV, EBV, JCV, VZV chronic infection with respiratory/GI viruses * _No B cells_: Enteroviral encephalitis, poliovirus (live vaccine contraindicated) * Fungi/parasites * _No T cells_: Candida, PCP * _No B cells_: GI giardiasis (no IgA) * _No granulocyte_: Candida, Aspergillus
32
X-linked (Bruton) agammaglobulinemia * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B-cell disorder * Defect * Defect in **_B_**TK, a tyrosine kinase gene Ž--\> no **_B_** cell maturation. * X-linked recessive (increase in **_B_**oys). * Presentation * Recurrent bacterial and enteroviral infections after 6 months (decrease maternal IgG). * Findings * Normal CD19+ B cell count, decreased pro-B, decreased Ig of all classes. * Absent/scanty lymph nodes and tonsils.
33
Selective IgA deficiency * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B-cell disorder * Defect * Unknown. * Most common 1° immunodeficiency. * Presentation * Majority **_A_**symptomatic. * Can see **_A_**irway and GI infections, **_A_**utoimmune disease, **_A_**topy, **_A_**naphylaxis to Ig**_A_**-containing products. * Findings * IgA \< 7 mg/dL with normal IgG, IgM levels.
34
Common variable immunodeficiency * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B-cell disorder * Defect * Defect in B-cell differentiation. * Many causes. * Presentation * Can be acquired in 20s–30s * Increased risk of autoimmune disease, bronchiectasis, lymphoma, sinopulmonary infections. * Findings * Decreased plasma cells * Decreased immunoglobulins.
35
Thymic aplasia (DiGeorge syndrome) * Type of disorder * Defect * Presentation * Findings
* Type of disorder * T-cell disorder * Defect * 22q11 deletion * Failure to develop 3rd and 4th pharyngeal pouches Ž--\> absent thymus and parathyroids. * Presentation * Tetany (hypocalcemia), recurrent viral/fungal infections (T-cell deficiency), conotruncal abnormalities (e.g., tetralogy of Fallot, truncus arteriosus). * Findings * Decreased T cells, decreased PTH, decreased Ca2+. * Absent thymic shadow on CXR. * 22q11 deletion detected by FISH.
36
IL-12 receptor deficiency * Type of disorder * Defect * Presentation * Findings
* Type of disorder * T-cell disorder * Defect * Decreased Th1 response. * Autosomal recessive. * Presentation * Disseminated mycobacterial and fungal infections * May present after administration of BCG vaccine. * Findings * Decreased IFN-γ.
37
Autosomal dominant hyper-IgE syndrome (Job syndrome) * Type of disorder * Defect * Presentation * Findings
* Type of disorder * T-cell disorder * Defect * Deficiency of Th17 cells due to STAT3 mutation --\>Ž impaired recruitment of neutrophils to sites of infection. * Presentation * **_FATED_**: coarse **_F_**acies, cold (noninflamed) staphylococcal **_A_**bscesses, retained primary **_T_**eeth, increased Ig**_E_**, **_D_**ermatologic problems (eczema). * Findings * Increased IgE, decreased IFN-γ.
38
Chronic mucocutaneous candidiasis * Type of disorder * Defect * Presentation * Findings
* Type of disorder * T-cell disorder * Defect * T-cell dysfunction. * Many causes. * Presentation * Noninvasive Candida albicans infections of skin and mucous membranes. * Findings * Absent in vitro T-cell proliferation in response to Candida antigens. * Absent cutaneous reaction to Candida antigens.
39
Severe combined immunodeficiency (SCID) * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B- and T-cell disorder * Defect * Several types including defective IL-2R gamma chain (most common, X-linked), adenosine deaminase deficiency (autosomal recessive). * Presentation * Failure to thrive, chronic diarrhea, thrush. * Recurrent viral, bacterial, fungal, and protozoal infections. * Treatment: bone marrow transplant (no concern for rejection). * Findings * Decreased T-cell receptor excision circles (TRECs). * Absence of thymic shadow (CXR), germinal centers (lymph node biopsy), and T cells (flow cytometry).
40
Ataxia-telangiectasia * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B- and T-cell disorder * Defect * Defects in ATM gene Ž--\> DNA double strand breaks --\>Ž cell cycle arrest. * Presentation * Triad: cerebellar defects (**_A_**taxia), spider **_A_**ngiomas (telangiectasia), Ig**_A_** deficiency. * Findings * Increased AFP. * Decreased IgA, IgG, and IgE. * Lymphopenia, cerebellar atrophy.
41
Hyper-IgM syndrome * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B- and T-cell disorder * Defect * Most commonly due to defective CD40L on Th cells = class switching defect * X-linked recessive. * Presentation * Severe pyogenic infections early in life * Opportunistic infection with Pneumocystis, Cryptosporidium, CMV. * Findings * Increased IgM. * Decreased IgG, IgA, IgE.
42
Wiskott-Aldrich syndrome * Type of disorder * Defect * Presentation * Findings
* Type of disorder * B- and T-cell disorder * Defect * Mutation in WAS gene (X-linked recessive) * T cells unable to reorganize actin cytoskeleton. * Presentation * **_WATER_**: **_W_**iskott-**_A_**ldrich: **_T_**hrombocytopenic purpura, **_E_**czema, **_R_**ecurrent infections. * Increased risk of autoimmune disease and malignancy. * Findings * Decreased to normal IgG, IgM. * Increased IgE, IgA. * Fewer and smaller platelets.
43
Leukocyte adhesion deficiency (type 1) * Type of disorder * Defect * Presentation * Findings
* Type of disorder * Phagocyte dysfunction * Defect * Defect in LFA-1 integrin (CD18) protein on phagocytes * Impaired migration and chemotaxis * Autosomal recessive. * Presentation * Recurrent bacterial skin and mucosal infections, absent pus formation, impaired wound healing, delayed separation of umbilical cord (\>30 days). * Findings * Increased neutrophils. * Absence of neutrophils at infection sites.
44
Chédiak-Higashi syndrome * Type of disorder * Defect * Presentation * Findings
* Type of disorder * Phagocyte dysfunction * Defect * Defect in lysosomal trafficking regulator gene (LYST). * Microtubule dysfunction in phagosome-lysosome fusion * Autosomal recessive. * Presentation * Recurrent pyogenic infections by staphylococci and streptococci, partial albinism, peripheral neuropathy, progressive neurodegeneration, infiltrative lymphohistiocytosis. * Findings * Giant granules in neutrophils and platelets. * Pancytopenia. * Mild coagulation defects.
45
Chronic granulomatous disease * Type of disorder * Defect * Presentation * Findings
* Type of disorder * Phagocyte dysfunction * Defect * Defect of NADPH oxidase --\> decreasedސ reactive oxygen species (e.g., superoxide) and absent respiratory burst in neutrophils * X-linked recessive. * Presentation * Increased susceptibility to catalase (+) organisms (**_PLACESS_**): **_P_**seudomonas, **_L_**isteria, **_A_**spergillus, **_C_**andida, **_E_**. coli, **_S_**. aureus, **_S_**erratia. * Findings * Abnormal dihydrorhodamine (flow cytometry) test. * Nitroblue tetrazolium dye reduction test is (-) (test out of favor).
46
Grafts * Autograft * Syngeneic graft * Allograft * Xenograft
* Autograft * From self. * Syngeneic graft * From identical twin or clone. * Allograft * From nonidentical individual of same species. * Xenograft * From different species.
47
Hyperacute transplant rejection * Onset * Pathogenesis * Features
* Onset * Within minutes * Pathogenesis * Pre-existing recipient antibodies react to donor antigen (type II reaction), activate complement. * Features * Widespread thrombosis of graft vessels --\>Ž ischemia/necrosis. * Graft must be removed.
48
Acute transplant rejection * Onset * Pathogenesis * Features
* Onset * Weeks to months * Pathogenesis * Cellular: CTLs activated against donor MHCs. * Humoral: similar to hyperacute, except antibodies develop after transplant. * Features * Vasculitis of graft vessels with dense interstitial lymphocytic infiltrate. * Prevent/reverse with immunosuppressants.
49
Chronic transplant rejection * Onset * Pathogenesis * Features
* Onset * Months to years * Pathogenesis * Recipient T cells perceive donor MHC as recipient MHC and react against donor antigens presented. * Both cellular and humoral components. * Features * Irreversible. * T-cell and antibody-mediated damage. * Organ specific: * Heart—atherosclerosis. * Lungs—bronchiolitis obliterans. * Liver—vanishing bile ducts. * Kidney—vascular fibrosis, glomerulopathy.
50
Graft-versus-host disease (transplant rejection) * Onset * Pathogenesis * Features
* Onset * Varies * Pathogenesis * Grafted immunocompetent T cells proliferate in the immunocompromised host and reject host cells with “foreign” proteins --\>Ž severe organ dysfunction. * Features * Maculopapular rash, jaundice, diarrhea, hepatosplenomegaly. * Usually in bone marrow and liver transplants (rich in lymphocytes). * Potentially beneficial in bone marrow transplant for leukemia (graft-versus-tumor effect).